ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,02
0,27%
Bitcoin
68 394,72
0,95%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nuvectis Pharma Inc (NVCT)

  7. Nuvectis Pharma Inc (NVCT) Actualités

NVCT

Nuvectis Pharma (NVCT)

Nuvectis Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVCT
DateHeureSourceTitreSymboleSociété
13/05/202414h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
07/05/202422h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
07/05/202415h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
05/03/202423h20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
09/08/202322h51Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVCTNuvectis Pharma Inc
27/06/202314h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVCTNuvectis Pharma Inc
16/06/202322h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVCTNuvectis Pharma Inc
10/05/202322h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVCTNuvectis Pharma Inc
28/04/202322h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVCTNuvectis Pharma Inc
03/04/202314h16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVCTNuvectis Pharma Inc
30/03/202312h09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVCTNuvectis Pharma Inc
27/03/202314h31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVCTNuvectis Pharma Inc
17/03/202321h32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVCTNuvectis Pharma Inc
08/03/202323h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVCTNuvectis Pharma Inc
09/01/202316h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVCTNuvectis Pharma Inc
14/09/202212h15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
15/08/202215h10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVCTNuvectis Pharma Inc
10/08/202222h31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVCTNuvectis Pharma Inc
05/08/202216h45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
21/06/202215h56TipRanksNuvectis Pharma (NVCT) Receives a Buy from H.C. WainwrightNASDAQ:NVCTNuvectis Pharma Inc
11/04/202218h25TipRanksAnalysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
05/04/202212h16TipRanksH.C. Wainwright Keeps Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
28/03/202223h23Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVCTNuvectis Pharma Inc
24/03/202218h16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVCTNuvectis Pharma Inc
24/03/202213h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVCTNuvectis Pharma Inc
22/03/202215h55TipRanksH.C. Wainwright Reiterates Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
09/03/202219h46TipRanks3 Under-the-Radar Stocks Ready to Bounce; Analysts Say ‘Buy’NASDAQ:NVCTNuvectis Pharma Inc
08/03/202215h17Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:NVCTNuvectis Pharma Inc
02/03/202212h18TipRanksH.C. Wainwright Initiates a Buy Rating on Nuvectis Pharma, Inc. (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:NVCT

Dernières Valeurs Consultées

EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
NYSE
NKE
Nike
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
EU
SGO
Cie de SaintGobain
EU
EN
Bouygues
EU
DG
Vinci
EU
AF
Air FranceKLM
EU
CAP
Capgemini
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés